40 filings
6-K
RDHL
Redhill Biopharma Ltd.
17 Dec 19
RedHill Biopharma Initiates U.S. Promotion of Aemcolo® for Travelers’ Diarrhea
8:00am
6-K
RDHL
Redhill Biopharma Ltd.
21 Nov 19
Current report (foreign)
8:00am
6-K
RDHL
Redhill Biopharma Ltd.
20 Nov 19
Current report (foreign)
7:00am
6-K
RDHL
Redhill Biopharma Ltd.
19 Nov 19
Current report (foreign)
7:00am
6-K
RDHL
Redhill Biopharma Ltd.
15 Nov 19
Current report (foreign)
8:00am
6-K
shw6bfohmsl3f6bo1iq
13 Nov 19
Current report (foreign)
7:00am
6-K
o2axx5 lbad2io
12 Nov 19
RedHill Biopharma Announces Publication of RHB-102 Gastroenteritis Phase 3 Study Results in JAMA
7:00am
6-K
qn6r8j
4 Nov 19
RedHill Biopharma Announces FDA Approval of Talicia® for Treatment of H. pylori in Adults
6:05am
6-K
mmuto1 ukk
29 Oct 19
RedHill Biopharma to Present at the BIO-Europe 2019 Conference
8:00am
6-K
mgq lpqj30s3mpl
28 Oct 19
RedHill Biopharma to Present New Phase 3 Data on RHB-105 and RHB-104 at the American College of Gastroenterology 2019 Annual Meeting
9:03am
6-K
k3rkmm431bqxhodr
18 Oct 19
RedHill Biopharma Announces $36 Million Strategic Investment by Cosmo Pharmaceuticals and U.S. Rights to Approved Travelers’ Diarrhea Drug AEMCOLO
6:00am
6-K
pvida8lxas7zhyvxa
16 Oct 19
Current report (foreign)
8:00am
6-K
q4ihwilozeqvv43pb
11 Oct 19
Current report (foreign)
9:00am
6-K
wem9zg8pm di7w
30 Sep 19
Current report (foreign)
6:30am
6-K
3cbcjunivj
26 Sep 19
RedHill Biopharma Provides H2/2019 R&D Update
8:00am
6-K
gtl 8l7j6k
27 Aug 19
RedHill Biopharma to Present at Upcoming Investor Conferences in September
7:00am
6-K
kg2232xk3 gul
21 Aug 19
Current report (foreign)
7:00am
6-K
f3zm38x4o3o3
23 Jul 19
Current report (foreign)
8:31am
6-K
ft8td0o
23 Jul 19
Current report (foreign)
7:27am
6-K
oey6b usw
15 Jul 19
Current report (foreign)
7:00am